NCT03446768

Brief Summary

The O2VERLAP study investigators would like to find out if individuals living with both COPD and OSA would benefit from an online, educational curriculum, coupled with access to peer support (i.e. telephone and online chatting with peers) and remote CPAP adherence monitoring data. The curriculum and peer coaching is meant to provide participants the information and tools they need to be more compliant in using their CPAP device.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
294

participants targeted

Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Feb 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2018

Completed
17 days until next milestone

Study Start

First participant enrolled

February 1, 2018

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 27, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2019

Completed
2.1 years until next milestone

Results Posted

Study results publicly available

December 3, 2021

Completed
Last Updated

December 3, 2021

Status Verified

October 1, 2021

Enrollment Period

1.7 years

First QC Date

January 15, 2018

Results QC Date

September 30, 2021

Last Update Submit

October 28, 2021

Conditions

Keywords

COPDOSA

Outcome Measures

Primary Outcomes (1)

  • Change in CPAP Adherence at 6 Weeks

    CPAP adherence is being measured through remote adherence monitoring of all participants; the study inclusion criteria requires all participants be using a CPAP device with wireless modem, the wireless modem allows the study investigators to accurately measure participants CPAP usage daily. Participants CPAP device record the 'total time connected' each day or total time the device is being used (i.e. units are hours per day). Study investigators will retroactively access and collect 30-days of baseline adherence data, prior to randomization, to measure the participants level of baseline adherence. The study investigators will then track participants total time using their CPAP device in hours, each day, for the duration of the participants enrollment (i.e. about three months).

    6 weeks

Secondary Outcomes (1)

  • Change in Daytime Functioning at 6 and12 Weeks

    6 weeks and 12 weeks

Other Outcomes (1)

  • Change in Sleep Quality at 6 and 12 Weeks

    6 weeks and 12 weeks

Study Arms (2)

Reactive Care (RC)

ACTIVE COMPARATOR

Participants in the RC arm of the study will be provided access to the COPD Information Line if they feel they would benefit from the support of a peer health coach. Peer health coaches working the information line are patients also living with COPD who can offer peer level support.

Other: Peer support

Proactive Care (PC)

ACTIVE COMPARATOR

Participants in the PC arm of the study will be provided access to the COPD Information Line if they feel they would benefit from the support of a peer health coach. Peer health coaches working the information line are patients also living with COPD who can offer peer level support. Additionally, the PC group will also receive access to an online study portal which houses an educational health curriculum covering topics related to COPD and OSA. The portal allows participants to send online messages to peer coaches and respiratory therapist coaches. PC group will also receive weekly updates.

Other: Peer supportOther: Online platformOther: Respiratory Therapist support

Interventions

Access to educational and informational support by a trained peer coach

Proactive Care (PC)Reactive Care (RC)

An online platform that provides educational, informational and access to several therapeutic device metrics

Proactive Care (PC)

Limited medical support provided by trained Respiratory Therapists.

Proactive Care (PC)

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: \>40 years
  • Primary language: English
  • Diagnosed with both Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)
  • Prescription for positive airway pressure therapy (PAP). There should be no minimum or maximum flow required (i.e., no limitation on PAP modality).
  • Access to the internet viand a PC, tablet, or smart phone to complete all study activities from home or remotely
  • PAP device with wireless modem

You may not qualify if:

  • Non-English speakers
  • Life expectancy less than or equal to six months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COPD Foundation Inc.

Miami, Florida, 33134, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveSleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsSleep Apnea SyndromesApneaRespiration DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Limitations and Caveats

The study utilized a national, electronic only recruitment method, which was primarily focused on the chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) communities. This may have resulted in a sample of participants who are more actively involved online seeking information and support for their medical condition. Future studies would benefit from recruiting a more diverse sample of patients on a number of dimensions.

Results Point of Contact

Title
Carl Stepnowsky, PhD
Organization
University of California, San Diego, La Jolla, CA

Study Officials

  • Carl Stepnowsky, PhD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR
  • Elisha Malanga, BS

    COPD Foundation

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2018

First Posted

February 27, 2018

Study Start

February 1, 2018

Primary Completion

October 31, 2019

Study Completion

October 31, 2019

Last Updated

December 3, 2021

Results First Posted

December 3, 2021

Record last verified: 2021-10

Locations